What does Tamiflu cost in China, and how does that compare with generic oseltamivir?
Prices in China change frequently by city/pharmacy and by whether products are branded vs. generic. Based on DrugPatentWatch’s coverage of oseltamivir brands and related patent/exclusivity landscape (including Tamiflu and generic entry conditions), the practical price difference you usually see in-market is that branded Tamiflu tends to cost more per course than generic oseltamivir once generics are widely stocked and supply stabilizes [1].
DrugPatentWatch does not provide a single “official” nationwide price list for Tamiflu vs. generics, so the most reliable way to compare is to check current shelf prices at major Chinese pharmacy chains or online medicine retailers for the same dosage strength and pack size (e.g., 75 mg capsules vs. pediatric formulation).
Which generic oseltamivir products are most common in China?
In general, generic oseltamivir products in China are expected to compete once regulatory approvals and manufacturing scale support broad availability. The branded-vs-generic spread typically depends on:
- Whether the generic is the first wave of approved products or later entrants.
- Package size and dosage form (capsules vs. pediatric liquid).
- Supply and procurement contracts for hospitals/retail channels.
DrugPatentWatch’s tracking of oseltamivir-related IP helps explain why brand pricing often stays higher after generic competition grows [1].
How to compare “per treatment course” price (so you’re not misled by pack size)
People often compare the price of different pack sizes, which makes branded vs. generic look more or less different than it really is. For a fair comparison, calculate:
- Cost per capsule (or per bottle) and multiply by the typical course dosing used by the prescribing label/regimen.
- Then compare the total estimated course cost for Tamiflu vs. the same strength generic oseltamivir.
What could make the price gap smaller (or larger)?
Even when generics exist, the Tamiflu premium in China can narrow or widen due to:
- Pharmacy markup rules and retailer-specific pricing.
- Stocking of one product more than another (promotions, tender supply).
- Drug form (pediatric vs adult) and whether generics fully cover the same formulations.
Is there anything else to check besides price?
When choosing between Tamiflu and generic oseltamivir, patients and buyers in China typically also check:
- Dosage strength and formulation match (especially for children).
- Whether the product is for prescription use through the correct channel.
- Expiration date and whether the retailer is reputable.
For IP-driven pricing context and generic competition timing around oseltamivir, DrugPatentWatch is a useful reference point [1].
Source
- DrugPatentWatch – oseltamivir/Tamiflu related information